LETTER
Preparation of 1,3,5-Substituted 2,4,6-Trimethoxybenzenes
2441
recrystallization from heptane. Yield: 0.517 g (23%); mp
(15) 2,2′,2′′-{[{[(2,4,6-Trimethoxybenzene-1,3,5-
93.5–95 °C. 1H NMR (500 MHz, CDCl3): δ = 5.12 (s, 3 H),
4.39 (d, 6 H), 3.81 (s, 9 H), 1.44 (s, 27 H). 13C NMR (125
MHz, CDCl3): δ = 158.5, 155.1, 122.6, 79.1, 62.4, 34.8,
28.6. HRMS: m/z [M + Na]+ calcd for C27H45N3O9Na+:
578.3048; found: 578.3069.
triyl)tris(methylene)]tris(azanediyl)}tris(carbonyl)]tris-
(azanediyl)}tris[3-(tritylthio)propanoic Acid] (8): The
triamine 3 (100 mg, 0.200 mmol) was dissolved in DMF (10
mL) and a solution of 1,1′-carbonyldiimidazole (100.9 mg,
0.622 mmol) in MeCN (10 mL) was added. The reaction
mixture was stirred for an hour and S-tritylcysteine (233.5
mg, 0.643 mmol) and Et3N (0.142 mL, 1 mmol) were added.
The reaction mixture was stirred overnight whereafter the
volatiles were removed. The residue was redissolved in
CHCl3 and washed with 0.5 M HCl (3 × 50 mL). The organic
phase was dried over Na2SO4, filtered and concentrated in
vacuo. The product was further purified by preparative
HPLC to give a white solid material. Yield: 121 mg (45%);
mp 177–179 °C. 1H NMR (500 MHz, DMSO-d6): δ = 12.70
(s, 3 H), 7.17–7.40 (m, 45 H), 6.42 (d, J = 8.3 Hz, 3 H), 6.30
(t, J = 5.4 Hz, 3 H), 4.25 (d, J = 5.4 Hz, 6 H), 4.20 (ddd, J =
8.3, 6.8, 5.1 Hz, 3 H), 3.72 (s, 9 H), 2.41 (dd, J = 11.7, 6.8
Hz, 3 H), 2.33 (dd, J = 11.7, 5.1 Hz, 3 H). 13C NMR (125
MHz, DMSO-d6): δ = 172.60, 158.04, 156.69, 144.16,
129.00, 128.03, 126.78, 122.54, 65.80, 62.13, 51.60, 34.31,
(10) Trimethyl 4,4′,4′′-[{[(2,4,6-Trimethoxybenzene-1,3,5-
triyl)tris(methylene)]tris(azanediyl)}tris(carbonyl)]tri-
benzoate (5): Iodine (458 mg, 1.81 mmol) was added to an
ice-cooled solution of trimethyl phosphite (0.213 mL, 1.81
mmol) in CH2Cl2 (40 mL). When all the iodine had
dissolved, terephthalic acid monomethyl ester (325 mg, 1.81
mmol) and Et3N (1.12 mL, 8.03 mmol) were added and the
solution was stirred for 20 min under continued cooling. The
triamide 3 (200 mg, 0.401 mmol) was added and the mixture
was stirred for 10 min at 0 °C and for 3 h at 25 °C. Sat.
NaHCO3 was added and the aqueous phase was extracted
with CH2Cl2 (50 mL). The organic phase was washed with 2
M HCl (2 × 50 mL) and brine (50 mL), dried over Na2SO4,
and filtered. The product was further purified by dry column
chromatography (Ø = 40 mm, h = 40 mm, CH2Cl2 to 12%
MeOH in CH2Cl2 with 1.5% gradient). Yield: 0.31 g (66%);
mp 212–213 °C. 1H NMR (500 MHz, DMSO-d6): δ = 8.60
(t, J = 4.8 Hz, 3 H), 7.94–8.02 (m, 12 H), 4.58 (d, J = 4.8 Hz,
6 H), 3.88 (s, 9 H), 3.83 (s, 9 H). 13C NMR (125 MHz,
DMSO-d6): δ = 165.69, 165.21, 158.98, 138.58, 131.60,
128.98, 127.75, 121.01, 62.17, 52.33, 33.92. HRMS: m/z [M
+ H]+ calcd for C39H40N3O12+: 742.2607; found: 742.2613.
(11) 2,2′,2′′-[(2,4,6-Trimethoxybenzene-1,3,5-
+
33.03. HRMS: m/z [M + H]+ calcd for C81H79N6O12S3 :
1423.4913; found: 1423.4884.
(16) 3,3′,3′′-{[{[(2,4,6-Trimethoxybenzene-1,3,5-
triyl)tris(methylene)]tris(azanediyl)}tris(carbonyl)]tris-
(azanediyl)}tribenzoic Acid (9): The triamine 3 (202 mg,
0.406 mmol) was dissolved in DMF (20 mL) and a solution
of 1,1′-carbonyldiimidazole (3.1 equiv, 204 mg, 1.26 mmol)
in MeCN (20 mL) was added. The reaction mixture was
stirred for an hour at r.t. 3-Aminobenzoic acid (3.2 equiv,
178 mg, 1.30 mmol), Et3N (21.2 equiv, 1.2 mL, 8.6 mmol)
and DMAP (0.1 equiv, 5.1 mg, 0.042 mmol) were added and
the reaction mixture was stirred for 3 d. Thereafter, the
reaction mixture was poured into an ice-cold solution of 2 M
HCl, the precipitate was filtered off and dried in vacuo.
Finally, the crude product was washed once with 2 M NaOH
(20 mL), reacidified with 2 M HCl, filtered and dried in
vacuo. Yield: 62.9 mg (21%). 1H NMR (500 MHz, DMSO-
d6): δ = 9.24 (s, 3 H), 8.06 (s, 3 H), 7.58 (d, J = 7.7 Hz, 3 H),
7.44 (d, J = 7.7 Hz, 3 H), 7.31 (t, J = 7.7 Hz, 3 H), 6.57 (s, 3
H), 4.38 (s, 6 H), 3.84 (s, 9 H). 13C NMR (125 MHz,
DMSO): δ = 167.36, 158.22, 154.79, 140.90, 131.19,
128.78, 122.34, 121.73, 121.48, 118.00, 62.37, 32.98.
HRMS: m/z [M + H]+ calcd for C36H37N6O12+: 745.2464;
found: 745.2489.
(17) Trimethyl 2,2′,2′′-{[{[(2,4,6-Trimethoxybenzene-1,3,5-
triyl)tris(methylene)]tris(azanediyl)}tris(carbonyl)]tris-
(azanediyl)}tris{3-[(4-methoxybenzyl)thio]propanoate}
(10): The PMB-protected cysteine (234 mg, 0.830 mmol)
was dissolved in DMF (20 mL) and a solution of 1,1′-
carbonyldiimidazole (143.1 mg, 0.883 mmol) in MeCN (20
mL) was added. The mixture was stirred for 30 min and the
triamine 3 (100 mg, 0.201 mmol) and imidazole (136 mg,
2.00 mmol) were added. The reaction mixture was stirred
overnight whereafter the volatiles were removed. The
residues were redissolved in CH2Cl2 (80 mL) and washed
with 0.5 M HCl (3 × 50 mL) and brine. The organic phase
was dried over Na2SO4, filtered, and concentrated in vacuo.
The product was further purified by dry column
triyl)tris(methylene)]tris(isoindoline-1,3-dione) (6):
1,3,5-Trimethoxybenzene (500 mg, 2.97 mmol) and N-
hydroxymethylphthalimide (1.65 g, 9.31 mmol) were
dissolved in boron triflouride etherate (25 mL) by gentle
heating. Afterwards the solution was stirred at 25 °C for 3 h.
The reaction mixture was poured into an ice–sodium acetate
mixture (100 g/15 g) and stirred for an hour. The aqueous
phase was extracted with CH2Cl2 (3 × 50 mL) and the
combined organic phase was washed with H2O (50 mL),
dried over Na2SO4, filtered and concentrated in vacuo. The
product was further purified by dry column chromatography
(Ø = 40 mm, h = 40 mm, toluene to 15% MeCN in toluene
with 3% gradient). Yield: 0.31 g (16%); mp 223–224 °C. 1H
NMR (500 MHz, DMSO-d6): δ = 7.65–7.78 (m, 12 H), 4.77
(s, 6 H), 3.73 (s, 9 H). 13C NMR (125 MHz, DMSO-d6): δ =
167.24, 158.18, 134.22, 131.30, 122.73, 119.02, 61.82,
+
32.27. HRMS: m/z [M + H]+ calcd for C36H28N3O9 :
646.1820; found: 646.1794.
(12) Gali, H.; Prabhu, K. R.; Karra, S. R.; Katti, K. V. J. Org.
Chem. 2000, 65, 676.
(13) 1,1′,1′′-[(2,4,6-Trimethoxybenzene-1,3,5-
triyl)tris(methylene)]tris[3-(tert-butyl)urea] (7): The
triamine 3 (200 mg, 0.402 mmol) was suspended in CH2Cl2–
Et3N (50 mL, 9:1) and tert-butylisocyanate (318 mg, 3.21
mmol) was added. The reaction mixture was stirred for 3 d
at 25 °C. The volatiles were removed in vacuo and the
residues were redissolved in CH2Cl2 (75 mL) and washed
with 1 M hydrochloric acid (2 × 30 mL) and brine. The
product was further purified by preparative HPLC, to yield
58% yield of a white solid; mp 275 °C (dec.). 1H NMR (500
MHz, DMSO-d6): δ = 5.83 (s, 3 H), 5.71 (t, J = 5.3 Hz, 3 H),
chromatography (Ø = 40 mm, h = 40 mm, CH2Cl2 to 5%
MeOH in CH2Cl2 with 0.5% gradient) to yield a white solid.
Yield: 65 mg (28%); mp 195 °C (dec.). 1H NMR (500 MHz,
DMSO-d6): δ = 7.19 (d, J = 8.7 Hz, 6 H), 6.86 (d, J = 8.7 Hz,
6 H), 6.52 (d, J = 8.2 Hz, 3 H), 6.32 (t, J = 5.3 Hz, 3 H), 4.38–
4.49 (m, 3 H), 4.27 (d, J = 5.3 Hz, 6 H), 3.74 (s, 9 H), 3.72
(s, 9 H), 3.67 (s, 6 H), 3.61 (s, 9 H), 2.71 (dd, J = 13.6, 5.3
Hz, 3 H), 2.65 (dd, J = 13.6, 6.8 Hz, 3 H). 13C NMR (125
4.20 (d, J = 5.3 Hz, 6 H), 3.73 (s, 9 H), 1.20 (s, 27 H). 13
C
NMR (125 MHz, DMSO-d6): δ = 157.80, 156.82, 122.90,
62.00, 48.93, 32.64, 29.31. HRMS: m/z [M + H]+ calcd for
+
C27H49N6O6 : 553.3708; found: 553.3717.
(14) Diness, F.; Beyer, J.; Meldal, M. QSAR Comb. Sci. 2004, 23,
117.
© Georg Thieme Verlag Stuttgart · New York
Synlett 2013, 24, 2437–2442